SCHEMBL20127670

SCHEMBL20127670

c1ccc2cc3c(ccc4c(-c5c6ccccc6c(-c6cc7c8ccccc8oc7c7c6oc6ccccc67)c6ccccc56)cccc43)cc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALOX5 P09917 2/20 0.36
AHR P35869 2/20 0.34
CYP1A2 P05177 2/20 0.34
ERBB2 P04626 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
CES1 P23141 1/20 0.33
HSD17B10 Q99714 4/20 0.33
HPGD P15428 3/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALPI P09923 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127673 0.91 L3MBTL1 (0.41) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL20412629 0.89 ALOX5 (0.41) SOS1ALOX5AHRCYP1A2ERBB2
SCHEMBL10122247 0.87 ALOX5 (0.40) L3MBTL1TDP1ALOX5AHRMAOA
SCHEMBL23504705 0.87 ALOX5 (0.46) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL20127446 0.86 SOS1 (0.39) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL20127640 0.86 ALOX5 (0.38) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL23504720 0.86 ALOX5 (0.45) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL24614792 0.86 SOS1 (0.36) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL23504556 0.85 SOS1 (0.37) SOS1L3MBTL1TDP1ALOX5AHR
SCHEMBL19081454 0.85 KDM4E (0.39) SOS1L3MBTL1ALOX5AHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 SOS1 960/4885L3MBTL1 1670/4885TDP1 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.